Both in Pharmaceuticals
Greenwich LifeSciences vs Immuneering
Over the past year GLSI returned +95.3% and IMRX returned −38.3%; their daily moves had a correlation of 0.28.
GLSI +95.3% IMRX −38.3%Growth of $1, one year, split-adjusted
| Metric | GLSI | IMRX |
|---|---|---|
| Price | $17.87 | $3.86 |
| Market cap | $262.3M | $249.4M |
| Today | −5.95% | −4.10% |
| 1 month | +3.0% | −4.3% |
| 6 months | −24.6% | −28.2% |
| Year to date | −14.9% | −41.4% |
| 1 year | +95.3% | −38.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.9M | $145.4M |
| Dividend yield | — | — |
| Volatility (60d) | 91.2% | 49.5% |
| Short % of float | 24.5% | 29.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).